Evidence map›Paper›PMID 34730152›Full record

ArticleNanoscale2021

Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous

Robin Bofinger, Gregory Weitsman, Rachel Evans, Matthias Glaser, Kerstin Sander, Helen Allan, Daniel Hochhauser, Tammy L Kalber, Erik Årstad, Helen C Hailes and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Robin BofingerDepartment of Chemistry, University College London, 20, Gordon Street, London WC1H 0AJ, UK. a.b.tabor@ucl.ac.uk.
Gregory WeitsmanSchool of Cancer and Pharmaceutical Sciences, King's College London, London, SE1 1UL, UK. tony.ng@kcl.ac.uk.ORCID http://orcid.org/0000-0002-1313-6279
Rachel EvansSchool of Cancer and Pharmaceutical Sciences, King's College London, London, SE1 1UL, UK. tony.ng@kcl.ac.uk.ORCID http://orcid.org/0000-0002-3723-2249
Matthias GlaserDepartment of Chemistry, University College London, 20, Gordon Street, London WC1H 0AJ, UK. a.b.tabor@ucl.ac.uk.
Kerstin SanderDepartment of Chemistry, University College London, 20, Gordon Street, London WC1H 0AJ, UK. a.b.tabor@ucl.ac.uk.ORCID http://orcid.org/0000-0002-6096-7577
Helen AllanDepartment of Chemistry, University College London, 20, Gordon Street, London WC1H 0AJ, UK. a.b.tabor@ucl.ac.uk.ORCID http://orcid.org/0000-0002-7186-4370
Daniel HochhauserUCL Cancer Institute, Paul O'Gorman Building, University College London, London WC1E 6DD, UK.
Tammy L KalberCentre for Advanced Biomedical Imaging, Paul O'Gorman Building, University College London, London WC1E 6DD, UK.ORCID http://orcid.org/0000-0002-3378-3748
Erik ÅrstadDepartment of Chemistry, University College London, 20, Gordon Street, London WC1H 0AJ, UK. a.b.tabor@ucl.ac.uk.
Helen C HailesDepartment of Chemistry, University College London, 20, Gordon Street, London WC1H 0AJ, UK. a.b.tabor@ucl.ac.uk.ORCID http://orcid.org/0000-0001-5574-4742
Tony NgSchool of Cancer and Pharmaceutical Sciences, King's College London, London, SE1 1UL, UK. tony.ng@kcl.ac.uk.ORCID http://orcid.org/0000-0003-3894-5619
Alethea B TaborDepartment of Chemistry, University College London, 20, Gordon Street, London WC1H 0AJ, UK. a.b.tabor@ucl.ac.uk.ORCID http://orcid.org/0000-0001-8216-0347
University College London · GBKing's College London · GBCRUK Lung Cancer Centre of Excellence · GB

Funding

Cancer Research UK 16463
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biosensing TechniquesNanoparticlesPharmaceutical PreparationsAnimalsCell Line, TumorErbB ReceptorsMiceProtein Kinase InhibitorsTissue DistributionErbB ReceptorsPharmaceutical PreparationsProtein Kinase Inhibitors

Identifiers

PMID34730152
PMCPMC8601123
OpenAlexW3211068415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.